Eurand Granted FDA Approval for Zenpep
Links shared publicly online about this topic.
- 1,787total visits
Eurand Granted FDA Approval for Zenpep
View full resource at drugs.com
Tags: Pancreatic Disease, FDA
Most Recently Shared on August 29, 2009 at 7:33 pm By:
Eurand Granted FDA Approval for Zenpep - http://bit.ly/3I6xA6
Eurand Announces Data On Switching Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency From Unapproved PEPs To FDA-Approved ZENPEP(R)
medicalnewstoday.com — “Eurand Pharmaceuticals, Inc., a subsidiary of global specialty pharmaceutical company Eurand N.V. (NASDAQ: EURX), announced additional data from a post-hoc analysis of a Phase III clinical trial w” View full resource at medicalnewstoday.com
Most Recently Shared on June 18, 2010 at 10:34 am By:
MNT Cystic Fibrosis Health News
Eurand Announces Data On Switching Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency From Unapproved PEP... http://mnt.to/3F2Z
Rx Product News Profile: A Closer Look at New FDA Actions: Eurand's Zenpep
pharmacytimes.com — “Eurand Pharmaceuticals' Zenpep (pancrelipase) Delayed-Release Capsules have been approved by” View full resource at pharmacytimes.com
Most Recently Shared on May 12, 2010 at 8:01 pm By:
A Closer at New FDA Actions: Eurand's Zenpep - Delayed-release capsules approved for exocrine pancreatic insufficiency http://bit.ly/cdVZwe
FDA clears Eurand's pancreatic enzyme drug Zenpep - Related Stories - AAP SmartBrief
smartbrief.com — “Eurand in Amsterdam gained FDA approval for its lead product, pancreatic enzyme drug Zenpep, for children age 1 and older as well as adults. The treatment, which is indicated for exocrine pancreatic insufficiency, will be available in four dosages in the U.S. next quarter. <a href='/servlet/aaRedire” View full resource at smartbrief.com
Most Recently Shared on September 1, 2009 at 3:02 am By:
Clara Song Physician, Doctor, and Pediatrician
FDA clears Eurand's pancreatic enzyme drug Zenpep http://sbne.ws/r/2FrT
Zenpep approved for exocrine pancreatic insufficiency (EPI) - MPR
empr.com — “The FDA has approved Zenpep (pancrelipase delayed-release capsules, from Eurand N.V.), a pancreatic enzyme product (PEP) for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) or other conditions.” View full resource at empr.com
Most Recently Shared on August 31, 2009 at 6:24 pm By:
MPR News: Zenpep approved for exocrine pancreatic insufficiency (EPI): The FDA has approved Zenpep (pan.. http://bit.ly/45RlgT
Advertisement
